Apr. 18, 2005 | |||||||||||||||||||||||||||||||||||||||||||||||
Advertising BioFact: |
Clinical Trials Breakfast Lecture: Under the New Regulatory Climate, May 10 - Seattle (pdf 155 kb) Fifth Annual Northwest Gene Expression Conference, May 25-27, Seattle...Sign up now! |
||||||||||||||||||||||||||||||||||||||||||||||
CEO Reading ListJanice M. LeCocq, Ph.D.Partner Collins Mabry & Co., L.L.C. San Francisco, CA Biography Dr. Janice M. LeCocq is a partner of Collins Mabry & Co., L.L.C., a San Francisco based consulting company. Dr. LeCocq is the former Chair and Chief Executive Officer of Gryphon Sciences. Prior to joining Gryphon in December 1994, Dr. LeCocq was Executive Vice President of Finance and Administration at ICOS Corporation in Seattle, Washington, and was previously a General Partner in Corporate Finance at Montgomery Securities, a leading investment banker for emerging growth companies. Dr. LeCocq also serves as a Director of Hyseq, and was previously a Director of ICOS Corporation and Molecular Dynamics. Education: Ph.D. Anthropology (Stanford University), AB Human Biology (Stanford University). Company Profile Collins Mabry & Co., L.L.C., is a San Francisco based company that provides consulting and advisory services to investors and entrepreneurs in the life sciences and health care industry. Collins Mabry provide due diligence assistance for potential new investments, strategic positioning and operational assistance for new businesses, and pragmatic, hands-on assistance in problem situations. Jan LeCocq's Suggested Reading List
Jan's Personal Favorites
|
|||||||||||||||||||||||||||||||||||||||||||||||
|